ICPD Technologies


ICPD began by integrating pre-clinical and clinical data through modeling and simulation to improve how antibiotic resistance is defined in the clinical microbiology laboratory. ICPD then developed the use of PK-PD-based dose regimen selection to ensure optimal patient drug exposures and thus, an increased likelihood of successful response during the antibiotic development process.

Schenectady NY
United States